ELDN Annual EBIT
-$43.00 M
-$3.22 M-8.09%
31 December 2023
Summary:
As of January 23, 2025, ELDN annual earnings before interest & taxes is -$43.00 million, with the most recent change of -$3.22 million (-8.09%) on December 31, 2023. During the last 3 years, it has fallen by -$26.82 million (-165.71%). ELDN annual EBIT is now -738.53% below its all-time high of -$5.09 million.ELDN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELDN Quarterly EBIT
-$20.51 M
-$6.01 M-41.43%
30 September 2024
Summary:
As of January 23, 2025, ELDN quarterly earnings before interest & taxes is -$20.51 million, with the most recent change of -$6.01 million (-41.43%) on September 30, 2024. Over the past year, it has dropped by -$9.31 million (-83.16%). ELDN quarterly EBIT is now -2100.64% below its all-time high of -$932.00 thousand, reached on June 30, 2016.ELDN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELDN TTM EBIT
-$56.22 M
-$9.31 M-19.85%
30 September 2024
Summary:
As of January 23, 2025, ELDN TTM earnings before interest & taxes is -$56.22 million, with the most recent change of -$9.31 million (-19.85%) on September 30, 2024. Over the past year, it has dropped by -$13.52 million (-31.65%). ELDN TTM EBIT is now -1570.70% below its all-time high of -$3.37 million, reached on September 30, 2013.ELDN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELDN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | -83.2% | -31.6% |
| 3 y3 years | -165.7% | -83.2% | -31.6% |
| 5 y5 years | -205.8% | -83.2% | -31.6% |
ELDN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.6% | at low | -120.9% | at low | -52.5% | at low |
| 5 y | 5-year | -203.2% | at low | -876.2% | at low | -425.5% | at low |
| alltime | all time | -738.5% | +5.0% | -2100.6% | at low | -1570.7% | at low |
Eledon Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.51 M(+41.4%) | -$56.22 M(+19.9%) |
| June 2024 | - | -$14.50 M(+33.4%) | -$46.91 M(+9.7%) |
| Mar 2024 | - | -$10.87 M(+5.1%) | -$42.76 M(-0.6%) |
| Dec 2023 | -$43.00 M(+8.1%) | -$10.34 M(-7.7%) | -$43.00 M(+0.7%) |
| Sept 2023 | - | -$11.20 M(+8.2%) | -$42.70 M(+1.4%) |
| June 2023 | - | -$10.35 M(-6.8%) | -$42.10 M(+2.6%) |
| Mar 2023 | - | -$11.11 M(+10.7%) | -$41.03 M(+3.1%) |
| Dec 2022 | -$39.78 M(+7.9%) | -$10.04 M(-5.3%) | -$39.78 M(+1.7%) |
| Sept 2022 | - | -$10.60 M(+14.2%) | -$39.13 M(+0.2%) |
| June 2022 | - | -$9.28 M(-5.8%) | -$39.03 M(+3.5%) |
| Mar 2022 | - | -$9.86 M(+5.1%) | -$37.72 M(+2.3%) |
| Dec 2021 | -$36.87 M(+127.8%) | -$9.38 M(-10.7%) | -$36.87 M(+8.9%) |
| Sept 2021 | - | -$10.51 M(+31.8%) | -$33.84 M(+22.3%) |
| June 2021 | - | -$7.97 M(-11.5%) | -$27.68 M(+26.9%) |
| Mar 2021 | - | -$9.01 M(+41.6%) | -$21.81 M(+34.8%) |
| Dec 2020 | -$16.18 M(+14.1%) | -$6.36 M(+46.3%) | -$16.18 M(+33.5%) |
| Sept 2020 | - | -$4.35 M(+106.9%) | -$12.13 M(+13.3%) |
| June 2020 | - | -$2.10 M(-37.8%) | -$10.70 M(-15.7%) |
| Mar 2020 | - | -$3.38 M(+46.9%) | -$12.69 M(-10.6%) |
| Dec 2019 | -$14.18 M(+0.9%) | -$2.30 M(-21.2%) | -$14.18 M(-13.8%) |
| Sept 2019 | - | -$2.92 M(-28.6%) | -$16.46 M(-3.4%) |
| June 2019 | - | -$4.09 M(-16.1%) | -$17.04 M(+5.6%) |
| Mar 2019 | - | -$4.88 M(+6.5%) | -$16.14 M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$14.06 M(+7.2%) | -$4.58 M(+30.8%) | -$14.06 M(+21.3%) |
| Sept 2018 | - | -$3.50 M(+9.7%) | -$11.59 M(+4.8%) |
| June 2018 | - | -$3.19 M(+14.1%) | -$11.05 M(-23.9%) |
| Mar 2018 | - | -$2.79 M(+32.8%) | -$14.53 M(+10.7%) |
| Dec 2017 | -$13.12 M(+155.9%) | -$2.10 M(-29.0%) | -$13.12 M(+5.1%) |
| Sept 2017 | - | -$2.96 M(-55.5%) | -$12.48 M(+12.1%) |
| June 2017 | - | -$6.67 M(+381.3%) | -$11.13 M(+106.2%) |
| Mar 2017 | - | -$1.39 M(-5.6%) | -$5.40 M(-65.1%) |
| Dec 2016 | -$5.13 M(-88.7%) | -$1.47 M(-9.3%) | -$15.50 M(-38.3%) |
| Sept 2016 | - | -$1.62 M(+73.5%) | -$25.10 M(-29.1%) |
| June 2016 | - | -$932.00 K(-91.9%) | -$35.39 M(-18.5%) |
| Mar 2016 | - | -$11.48 M(+3.7%) | -$43.44 M(-4.0%) |
| Dec 2015 | -$45.26 M(+92.9%) | -$11.07 M(-7.0%) | -$45.26 M(+11.9%) |
| Sept 2015 | - | -$11.91 M(+32.6%) | -$40.45 M(+15.7%) |
| June 2015 | - | -$8.98 M(-32.5%) | -$34.97 M(+9.7%) |
| Mar 2015 | - | -$13.30 M(+112.4%) | -$31.87 M(+35.8%) |
| Dec 2014 | -$23.46 M(+49.0%) | -$6.26 M(-2.5%) | -$23.46 M(+3.1%) |
| Sept 2014 | - | -$6.42 M(+9.2%) | -$22.75 M(+15.5%) |
| June 2014 | - | -$5.88 M(+20.3%) | -$19.69 M(+42.6%) |
| Mar 2014 | - | -$4.89 M(-11.8%) | -$13.81 M(+54.9%) |
| Dec 2013 | -$15.75 M(+63.2%) | -$5.55 M(+64.9%) | -$8.91 M(+164.9%) |
| Sept 2013 | - | -$3.37 M | -$3.37 M |
| Dec 2012 | -$9.65 M | - | - |
FAQ
- What is Eledon Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual EBIT year-on-year change?
- What is Eledon Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly EBIT year-on-year change?
- What is Eledon Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals TTM EBIT year-on-year change?
What is Eledon Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ELDN is -$43.00 M
What is the all time high annual EBIT for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual earnings before interest & taxes is -$5.09 M
What is Eledon Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ELDN annual earnings before interest & taxes has changed by -$3.22 M (-8.09%)
What is Eledon Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ELDN is -$20.51 M
What is the all time high quarterly EBIT for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$932.00 K
What is Eledon Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ELDN quarterly earnings before interest & taxes has changed by -$9.31 M (-83.16%)
What is Eledon Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ELDN is -$56.22 M
What is the all time high TTM EBIT for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high TTM earnings before interest & taxes is -$3.37 M
What is Eledon Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ELDN TTM earnings before interest & taxes has changed by -$13.52 M (-31.65%)